Femasys Logo
Main Menu

Resources

Find the latest news about Femasys, including our media mentions, scientific publications, and more.

Meet the metro Atlanta woman who invented a new permanent birth control

  • The Atlanta Journal-Constitution

The Future of Fertility and Non-Surgical Birth Control with Kathy Lee-Sepsick

  • Health Innovation Matters

Transforming women’s health: The power of Femtech and minimally invasive solutions

  • DOTmed

Intratubal insemination: Another Option in Fertility Treatment

  • Fertility Docs Uncensored

Femasys Offers a Fresh Take on Women’s Reproductive Healthcare

  • MD+DI

Disrupting Stagnant Women’s Reproductive Health Ecosystem with Safer More Accessible Options with Kathy Lee-Sepsick Femasys

  • Empowered Patient Podcast
Load More

Meet the metro Atlanta woman who invented a new permanent birth control

  • The Atlanta Journal-Constitution

The Future of Fertility and Non-Surgical Birth Control with Kathy Lee-Sepsick

  • Health Innovation Matters

Transforming women’s health: The power of Femtech and minimally invasive solutions

  • DOTmed

Intratubal insemination: Another Option in Fertility Treatment

  • Fertility Docs Uncensored

Femasys Offers a Fresh Take on Women’s Reproductive Healthcare

  • MD+DI

Disrupting Stagnant Women’s Reproductive Health Ecosystem with Safer More Accessible Options with Kathy Lee-Sepsick Femasys

  • Empowered Patient Podcast
Load More

Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed

  • GlobeNewswire

Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment

  • GlobeNewswire

Innovation in Women’s Reproductive Health is More Important than Ever

  • Medical Design & Development

Femasys Partners with Boston IVF to Expand Access to Novel Fertility Treatment

  • Femtech Insider

Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check

  • GlobeNewswire

Femasys secures CE mark certification for FemVue MINI solution

  • Medical Device Network
Load More

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine

  • GlobeNewswire

Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer

  • GlobeNewswire

Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch

  • GlobeNewswire

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech

  • GlobeNewswire

FemCerv®: Well-designed technology that can minimize patient discomfort

  • MDedge

The Post-Roe Fertility Journey

  • SXSW
Load More

VIDEO: President and CEO, Kathy Lee-Sepsick speaks to connecting with the audience

  • YouTube

VIDEO: President and CEO, Kathy Lee-Sepsick at SLS

  • YouTube

VIDEO: Femasys KOL Event

  • YouTube

Media Kits

For additional information, please email [email protected]

Corporate Kit

Infertility Kit

Contraception Kit

Biopsy Kit

About Femasys
Investor Relations
Resources
Contact Us
Healthcare Professionals
Patients
Privacy Policy
Terms of Use
Patents
Accessibility
Order
Copyright © 2024 Femasys Inc.
FemaSeed, FemBloc, FemCath, FemCerv, and FemVue are registered trademarks of Femasys Inc.
Main Menu